0000000001312385

AUTHOR

M. Follmann

showing 4 related works from this author

S3-Leitlinie Gesundheitsüberwachung bei Beryllium-Exposition und diagnostisches Vorgehen bei berylliumassoziierter Erkrankung

2013

Health surveillancechemistrybusiness.industryEnvironmental healthMedicinechemistry.chemical_elementGeneral MedicineBerylliumbusinessDMW - Deutsche Medizinische Wochenschrift
researchProduct

CCDC 165221: Experimental Crystal Structure Determination

2002

Related Article: M.Follmann, A.Rosch, E.Klegraf, H.Kunz|2001|Synlett||1569|doi:10.1055/s-2001-17460

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(4R)-34-dihydro-4-propyl-1-(2346-tetra-O-pivaloyl-beta-D-galactopyranosyl)pyridine-2(1H)-oneExperimental 3D Coordinates
researchProduct

CCDC 237631: Experimental Crystal Structure Determination

2005

Related Article: E.Klegraf, M.Follmann, D.Schollmeyer, H.Kunz|2004|Eur.J.Org.Chem.|2004|3346|doi:10.1002/ejoc.200400169

Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates(2R)-23-dihydro-2-phenyl-1-(2346-tetra-O-pivaloyl-beta-D-galactopyranosyl)pyridine-4(1H)-one
researchProduct

CCDC 237632: Experimental Crystal Structure Determination

2005

Related Article: E.Klegraf, M.Follmann, D.Schollmeyer, H.Kunz|2004|Eur.J.Org.Chem.|2004|3346|doi:10.1002/ejoc.200400169

Space GroupCrystallographyCrystal SystemCrystal Structure(2S3S)-23-dihydro-3-methyl-2-propyl-1-(2346-tetra-O-pivaloyl-beta-D-galactopyranosl)pyridine-4(1H)-oneCell ParametersExperimental 3D Coordinates
researchProduct